Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: Sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas

Cytogenetic studies in small groups of patients with malignant peripheral-nerve-sheath tumors (MPNST) revealed complex karyotypes with no consistent changes. A computer-assisted cytogenetic analysis using a cytogenetic database was performed to determine recurrent cytogenetic alterations in 51 MPNSTs (44 from the literature and 7 new cases) and to allow direct cytogenetic comparison between NF-l-associated and sporadic MPNSTs. Significant loss (p <0.05) was observed in the chromosomal regions 9p2, 11p1, 11q2 and 18p1. Also, loss in 1p3, 9p1, 11q1, 12q2, 17p1, 18q1-q2, 19p1, 22q1, X and Y was detected. Gain of chromosomal material was found in chromosome 7, especially 7q1 (p <0.05). Most involved breakpoints were: 1p13, 1q21, 7p22, 9p11, 17p11, 17q11, 22q11. Cytogenetic differences between NF-I-associated and sporadic MPNSTs included a relative loss of chromosomal material in NF-I-associated MPNSTs in 1p3, 4p1 and 21p1-q2 and a relative gain in 15p1-q1. Differences in breakpoints between the NF-I associated and the sporadic MPNST group were observed in 1p21-22 (28% of NF-I vs. 0% of sporadic MPNSTs), 1p32-34(17% vs. 0%), 8p11-12 (7% vs. 27%) and 17q10-12 (24% vs. 7%). This approach, in which the cytogenetic results of various reports are combined, shows that losses in 9p2 and gains in 7q1 could be of oncogenetic importance in MPNSTs. Lass of 17q1, on which the NF-I gene has been located (17q11.2), is not a common cytogenetic finding in NF-I-associated MPNSTs. The observed differences between NF-I-associated and sporadic MPNSTs might reflect different oncogenetic pathways. (C) 1999 Wiley-Liss, Inc.